Phillip Blanchette

1.6k total citations
58 papers, 1.0k citations indexed

About

Phillip Blanchette is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Phillip Blanchette has authored 58 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 23 papers in Pulmonary and Respiratory Medicine and 13 papers in Cancer Research. Recurrent topics in Phillip Blanchette's work include Bone health and treatments (9 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Breast Cancer Treatment Studies (8 papers). Phillip Blanchette is often cited by papers focused on Bone health and treatments (9 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Breast Cancer Treatment Studies (8 papers). Phillip Blanchette collaborates with scholars based in Canada, United Kingdom and United States. Phillip Blanchette's co-authors include Jacques Raphael, Gabriel Boldt, Ricardo Fernandes, Saman Maleki Vareki, S. M. Qasim Hussaini, Rania Chehade, Gideon Koren, Ted Vandenberg, Mihaela Mates and Mark Clemons and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Phillip Blanchette

52 papers receiving 1.0k citations

Peers

Phillip Blanchette
Yüksel Küçükzeybek Türkiye
Polly Niravath United States
Ann Vanderplas United States
Laurent Cany France
Halle C. F. Moore United States
Kristine M. Eilers United States
Anna Ceribelli Italy
Tochukwu Okwuosa United States
Hans Wildiers Belgium
Yüksel Küçükzeybek Türkiye
Phillip Blanchette
Citations per year, relative to Phillip Blanchette Phillip Blanchette (= 1×) peers Yüksel Küçükzeybek

Countries citing papers authored by Phillip Blanchette

Since Specialization
Citations

This map shows the geographic impact of Phillip Blanchette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip Blanchette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip Blanchette more than expected).

Fields of papers citing papers by Phillip Blanchette

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phillip Blanchette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip Blanchette. The network helps show where Phillip Blanchette may publish in the future.

Co-authorship network of co-authors of Phillip Blanchette

This figure shows the co-authorship network connecting the top 25 collaborators of Phillip Blanchette. A scholar is included among the top collaborators of Phillip Blanchette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phillip Blanchette. Phillip Blanchette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kwong, Jeffrey C., Lucie Richard, Jennifer Reid, et al.. (2024). The safety of seasonal influenza vaccination among adults prescribed immune checkpoint inhibitors: A self-controlled case series study using administrative data. Vaccine. 42(7). 1498–1505. 2 indexed citations
3.
Verma, Siddharth, Mark Vincent, Matthew J. Cecchini, et al.. (2024). EP.07C.15 Neoadjuvant Immuno-Chemotherapy in Resectable Non-Small Cell Lung Cancer - A Retrospective Cohort Study. Journal of Thoracic Oncology. 19(10). S546–S546.
4.
Fernandes, Ricardo, Terry L. Ng, Jacques Raphael, et al.. (2023). A Multi-Centre Randomized Study Comparing Two Standard of Care Chemotherapy Regimens for Lower-Risk HER2-Positive Breast Cancer. Current Oncology. 30(8). 7384–7397. 3 indexed citations
5.
Xiao, Tian, et al.. (2023). Antibody–Drug Conjugates in Breast Cancer: Ascent to Destiny and Beyond—A 2023 Review. Current Oncology. 30(7). 6447–6461. 18 indexed citations
6.
Chehade, Rania, et al.. (2023). Appraisal of Systemic Treatment Strategies in Early HER2-Positive Breast Cancer—A Literature Review. Cancers. 15(17). 4336–4336. 1 indexed citations
7.
8.
Wiener, Joshua, et al.. (2022). Cancer incidence and stage at diagnosis among people with psychotic disorders: Systematic review and meta-analysis. Cancer Epidemiology. 80. 102233–102233. 20 indexed citations
9.
Blanchette, Phillip, Melody Lam, Lucie Richard, et al.. (2021). The association between endocrine therapy use and osteoporotic fracture among post-menopausal women treated for early-stage breast cancer in Ontario, Canada. The Breast. 60. 295–301. 4 indexed citations
10.
Hussaini, S. M. Qasim, Rania Chehade, Gabriel Boldt, et al.. (2020). Association between immune-related side effects and efficacy and benefit of immune checkpoint inhibitors – A systematic review and meta-analysis. Cancer Treatment Reviews. 92. 102134–102134. 264 indexed citations
11.
Blanchette, Phillip, Prakesh S. Shah, Xiang Y. Ye, et al.. (2020). Do all patients with HER2 positive breast cancer require one year of adjuvant trastuzumab? A systematic review and meta-analysis. The Breast. 54. 203–210. 11 indexed citations
12.
Breadner, Daniel, et al.. (2020). Efficacy and safety of ALK inhibitors in ALK-rearranged non-small cell lung cancer: A systematic review and meta-analysis. Lung Cancer. 144. 57–63. 18 indexed citations
13.
Blanchette, Phillip, Melody Lam, Lucie Richard, et al.. (2020). The association between endocrine therapy use and dementia among post-menopausal women treated for early-stage breast cancer in Ontario, Canada. Journal of Geriatric Oncology. 11(7). 1132–1137. 9 indexed citations
14.
15.
McGee, Sharon F., Lisa Vandermeer, Sasha Mazzarello, et al.. (2018). Physician Survey of Timing of Adjuvant Endocrine Therapy Relative to Radiotherapy in Early Stage Breast Cancer Patients. Clinical Breast Cancer. 19(1). e40–e47. 8 indexed citations
16.
Blanchette, Phillip, Danielle Desautels, Gregory R. Pond, et al.. (2018). Factors influencing survival among patients with HER2-positive metastatic breast cancer treated with trastuzumab. Breast Cancer Research and Treatment. 170(1). 169–177. 14 indexed citations
17.
Blanchette, Phillip, J. H. Lipton, David Barth, & Helen Mackay. (2013). Case Report of Very Late Gastric Cancer Recurrence. Current Oncology. 20(2). 161–164. 9 indexed citations
18.
Chan, Daphne, Daniela Caprara, Phillip Blanchette, Julia Klein, & Gideon Koren. (2004). Recent developments in meconium and hair testing methods for the confirmation of gestational exposures to alcohol and tobacco smoke. Clinical Biochemistry. 37(6). 429–438. 66 indexed citations
19.
Klein, Julia, Phillip Blanchette, & Gideon Koren. (2004). Assessing nicotine metabolism in pregnancy—a novel approach using hair analysis. Forensic Science International. 145(2-3). 191–194. 32 indexed citations
20.
Blanchette, Phillip, Georges‐Étienne Rivard, Sara J. Israels, et al.. (2004). A survey of factor prophylaxis in the Canadian haemophilia A population. Haemophilia. 10(6). 679–683. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yüksel Küçükzeybek Breakdown of academic impact, for papers by Polly Niravath Breakdown of academic impact, for papers by Ann Vanderplas Breakdown of academic impact, for papers by Laurent Cany Breakdown of academic impact, for papers by Halle C. F. Moore Breakdown of academic impact, for papers by Kristine M. Eilers Breakdown of academic impact, for papers by Anna Ceribelli Breakdown of academic impact, for papers by Tochukwu Okwuosa Breakdown of academic impact, for papers by Hans Wildiers
Rankless by CCL
2026